Brought to you by 
Baxter Healthcare commercializes Rockwell's hemodialysis concentrates under long-term deal; Deal terminated
09 Nov 2022
Executive Summary
Rockwell Medical Inc. (treatments for end-stage renal disease and kidney disease) chose Baxter International Inc.’s Baxter Healthcare Corp. to exclusively sell its line of hemodialysis concentrates in the US and other select markets overseas.
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Baxter Healthcare commercializes Rockwell's hemodialysis concentrates under long-term deal; Deal terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice